Prostate Cancer - Results from #720

Multinational, Multicenter Evaluation of Prostate Cancer Tissue in Sub-Saharan Africa: Challenges and Opportunities. June 14, 2024

Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies. June 14, 2024

Racial and socioeconomic disparities in surgical care for post-prostate cancer treatment complications: A nationwide Medicare-based analysis. June 14, 2024

Estimating the impact of enhanced care at minority-serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers. June 14, 2024

The need for precision medicine in managing cardiovascular risk for men receiving ADT. June 14, 2024

Real-world clinical outcomes among patients with metastatic castration-sensitive prostate cancer initiating apalutamide. June 13, 2024

Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study. June 13, 2024

Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer. June 13, 2024

Nerve-sparing radical prostatectomy using the neurovascular structure-adjacent frozen-section examination (NeuroSAFE): results after 20 years of experience. June 13, 2024

Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer. June 13, 2024

Androgen Deprivation Therapy and Outcomes After Radiation Therapy in Black Patients With Prostate Cancer. June 12, 2024

Detection of clinically significant prostate cancer following initial omission of biopsy in multiparametric MRI era. June 12, 2024

Prostate cancer: nuclear medicine imaging in the biochemical recurrence and in oligometastatic disease. June 12, 2024

Race-related Differences in Sipuleucel-T Response Among Men with Metastatic Castrate-Resistant Prostate Cancer. June 12, 2024

New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy. June 12, 2024

Small cell neuroendocrine prostate cancer with adenocarcinoma components-case report and literature review. June 11, 2024

Research protocol for an observational health data analysis to assess the applicability of randomized controlled trials focusing on newly diagnosed metastatic prostate cancer using real-world data: PIONEER IMI's "big data for better outcomes" program. June 11, 2024

Acceptability of a virtual prostate cancer survivorship care model in rural Australia: A multi-methods, single-centre feasibility pilot. June 11, 2024

A phase II trial of apalutamide for intermediate-risk prostate cancer and molecular correlates. June 11, 2024

A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in Massachusetts. June 11, 2024

Page 37 of 1434